Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen cash Flow Statement — Operating cash flow ($M) ($M)
Form 10-Q / 10-K Consolidated Statements of Cash Flows (DB)
Latest, Q2 2026
4,002
Period ended Jun 30, 2026
Change on a year earlier
+75.5%
2,280 in Q2 2025
History
60 quarters
Since Q3 2008
Sources
51
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cash Flow Statement — Operating cash flow ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 4,002 | +75.5% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 2,189 | +57.4% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | 1,603 | -66.4% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2025 | Sep 30, 2025 | 4,684 | +31.2% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 2,280 | -7.3% | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | 1,391 | +101.9% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 4,771 | +786.8% | Form 10-K (filed 2025-02-14) ↗ |
| Q3 2024 | Sep 30, 2024 | 3,571 | +29.4% | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | 2,459 | -40.2% | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | 689 | -35.2% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 538 | -79.7% | Form 10-K (filed 2024-02-14) ↗ |
| Q3 2023 | Sep 30, 2023 | 2,760 | -7.3% | Form 10-Q (filed 2023-10-31) ↗ |
| Q2 2023 | Jun 30, 2023 | 4,109 | +112.9% | Form 10-Q (filed 2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | 1,064 | -50.8% | Form 10-Q (filed 2023-04-28) ↗ |
| Q4 2022 | Dec 31, 2022 | 2,649 | -5.7% | Form 10-K (filed 2023-02-09) ↗ |
| Q3 2022 | Sep 30, 2022 | 2,978 | – | Form 10-Q (filed 2022-11-04) ↗ |
| Q2 2022 | Jun 30, 2022 | 1,930 | – | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 2,164 | +2.9% | Form 10-Q (filed 2022-04-28) ↗ |
| Q4 2021 | Dec 31, 2021 | 2,808 | +30.4% | Form 10-K (filed 2022-02-16) ↗ |
| Q1 2021 | Mar 31, 2021 | 2,104 | -1.4% | Form 10-Q (filed 2021-04-28) ↗ |
| Q4 2020 | Dec 31, 2020 | 2,153 | – | Form 10-K (filed 2021-02-09) ↗ |
| Q3 2020 | Sep 30, 2020 | 3,368 | – | Form 10-Q (filed 2020-10-29) ↗ |
| Q2 2020 | Jun 30, 2020 | 2,842 | +101.0% | Form 10-Q (filed 2020-07-29) ↗ |
| Q1 2020 | Mar 31, 2020 | 2,134 | +15.7% | Form 10-Q (filed 2020-05-01) ↗ |
| Q2 2019 | Jun 30, 2019 | 1,414 | -32.7% | Form 10-Q (filed 2019-07-31) ↗ |
| Q1 2019 | Mar 31, 2019 | 1,845 | -32.3% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 3,194 | +6.0% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2018 | Sep 30, 2018 | 3,273 | -5.2% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jun 30, 2018 | 2,102 | -9.6% | Form 10-Q (filed 2018-07-27) ↗ |
| Q1 2018 | Mar 31, 2018 | 2,727 | +14.3% | Form 10-Q (filed 2018-04-25) ↗ |
| Q4 2017 | Dec 31, 2017 | 3,012 | -2.8% | Form 10-K (filed 2018-02-13) ↗ |
| Q3 2017 | Sep 30, 2017 | 3,454 | +29.8% | Form 10-Q (filed 2017-10-26) ↗ |
| Q2 2017 | Jun 30, 2017 | 2,326 | -13.1% | Form 10-Q (filed 2017-07-26) ↗ |
| Q1 2017 | Mar 31, 2017 | 2,385 | +24.5% | Form 10-Q (filed 2017-04-27) ↗ |
| Q4 2016 | Dec 31, 2016 | 3,100 | +49.5% | Form 10-K (filed 2017-02-14) ↗ |
| Q3 2016 | Sep 30, 2016 | 2,662 | -8.0% | Form 10-Q (filed 2016-10-28) ↗ |
| Q2 2016 | Jun 30, 2016 | 2,677 | -18.5% | Form 10-Q (filed 2016-07-29) ↗ |
| Q1 2016 | Mar 31, 2016 | 1,915 | +29.2% | Form 10-Q (filed 2016-05-02) ↗ |
| Q4 2015 | Dec 31, 2015 | 2,073 | -27.1% | Form 10-K (filed 2017-02-14) ↗ |
| Q3 2015 | Sep 30, 2015 | 2,892 | +5.5% | Form 10-Q (filed 2016-10-28) ↗ |
| Q2 2015 | Jun 30, 2015 | 3,284 | +47.5% | Form 10-Q (filed 2016-07-29) ↗ |
| Q1 2015 | Mar 31, 2015 | 1,482 | +29.8% | Form 10-Q (filed 2016-05-02) ↗ |
| Q4 2014 | Dec 31, 2014 | 2,842 | +54.9% | Form 10-K (filed 2017-02-14) ↗ |
| Q3 2014 | Sep 30, 2014 | 2,741 | – | Form 10-Q (filed 2014-10-29) ↗ |
| Q2 2014 | Jun 30, 2014 | 2,227 | – | Form 10-Q (filed 2014-08-05) ↗ |
| Q1 2014 | Mar 31, 2014 | 1,142 | +8.9% | Form 10-Q (filed 2014-04-30) ↗ |
| Q4 2013 | Dec 31, 2013 | 1,835 | +126.0% | Form 10-K (filed 2014-02-24) ↗ |
| Q1 2013 | Mar 31, 2013 | 1,049 | – | Form 10-Q (filed 2013-05-03) ↗ |
| Q4 2012 | Dec 31, 2012 | 812 | – | Form 10-K (filed 2013-02-27) ↗ |
| Q1 2011 | Mar 31, 2011 | 1,030 | +12.8% | Form 10-Q (filed 2011-05-10) ↗ |
| Q4 2010 | Dec 31, 2010 | 2,008 | +10.1% | Form 10-K (filed 2011-02-25) ↗ |
| Q3 2010 | Sep 30, 2010 | 1,302 | -34.1% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | 1,564 | -6.8% | Form 10-Q (filed 2010-08-09) ↗ |
| Q1 2010 | Mar 31, 2010 | 913 | +6.3% | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2009 | Dec 31, 2009 | 1,823 | +30.5% | Form 10-K (filed 2010-03-01) ↗ |
| Q3 2009 | Sep 30, 2009 | 1,975 | +42.1% | Form 10-Q (filed 2009-11-06) ↗ |
| Q2 2009 | Jun 30, 2009 | 1,679 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q1 2009 | Mar 31, 2009 | 859 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2008 | Dec 31, 2008 | 1,397 | – | Form 10-K (filed 2010-03-01) ↗ |
| Q3 2008 | Sep 30, 2008 | 1,390 | – | Form 10-Q (filed 2009-11-06) ↗ |
Breakdown
What makes up cash flow statement — operating cash flow ($m)
- Depreciation and amortization ($M)222 · Q2 2026
- Stock-based compensation ($M)165 · Q2 2026
- Deferred income taxes ($M)-291 · Q2 2026
- Change in trade receivables ($M)-1,093 · Q2 2026
- Change in inventories ($M)-31 · Q2 2026
- Change in accounts payable ($M)-70 · Q2 2026
- Capital expenditures ($M)513 · Q2 2026
- Net cash used in investing activities ($M)-569 · Q2 2026
- Proceeds from issuance of long-term debt ($M)0 · Q2 2026
- Repayments of long-term debt ($M)-0 · Q2 2026
- Cash dividends paid ($M)1,362 · Q2 2026
- Repurchases of common stock ($M)–
- Net cash used in financing activities ($M)-1,482 · Q2 2026
- Cash paid for interest, net ($M)–
- Cash paid for income taxes, net ($M)–
Cite this data
StockData. (2026). Amgen Cash Flow Statement — Operating cash flow ($M) ($M), quarterly Q3 2008–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_cash_flow
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.